Evaluation of Autologous Bone Marrow Concentrate along with Hydroxyapatite-collagen for Management of Long Bone Fracture in Canines

Author(s):  
Reshma Jain ◽  
B.P. Shukla ◽  
Supriya Shukla ◽  
Daljeet Chhabra ◽  
S.K. Karmore ◽  
...  

Background: Fractures are a major concern in Veterinary orthopedic surgery because they are often complicated into non unions. The present study was planned to evaluate the fracture healing by using hydroxyapatite-collagen (HAp-Col) as a bone graft substitute and autologous bone marrow concentrate, after the internal fixation by titanium elastic pin. Method: The present work was conducted on 12 clinical cases of dogs having diaphyseal fracture of long bones. In group I (6 animals) fractures were immobilized by an internal fixation technique. In group II fracture was immobilized as in group I with use of autologous bone marrow concentrate along with Hydroxyapatite-collagen at the fracture site. The weight bearing and the progress of fracture healing were recorded. Result: Study showed early weight bearing and no observable lameness in group II as compared to group I animals. Fracture union was earlier and with minimum periosteal callus formation in one animal, five animals at 45 days and 60 days respectively while in group I fracture healing was observed in one animal, two animals at 60 day and 90 days respectively. On basis of result, it is concluded that Hydroxyapatite-collagen composite can be used as along with autolologus bone marrow concentrate as alternative therapy to bone graft in clinical cases to enhance the fracture healing. The use of autogenous and allogenic bone graft having some advantages which is overcome by this present technique.

Stem Cells ◽  
2014 ◽  
Vol 33 (1) ◽  
pp. 146-156 ◽  
Author(s):  
Kenneth A. Pettine ◽  
Matthew B. Murphy ◽  
Richard K. Suzuki ◽  
Theodore T. Sand

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Christopher Centeno ◽  
John Pitts ◽  
Hasan Al-Sayegh ◽  
Michael Freeman

Introduction.We investigated the use of autologous bone marrow concentrate (BMC) with and without an adipose graft, for treatment of knee osteoarthritis (OA).Methods.Treatment registry data for patients who underwent BMC procedures with and without an adipose graft were analyzed. Pre- and posttreatment outcomes of interest included the lower extremity functional scale (LEFS), the numerical pain scale (NPS), and a subjective percentage improvement rating. Multivariate analyses were performed to examine the effects of treatment type adjusting for potential confounding factors. The frequency and type of adverse events (AE) were also examined.Results.840 procedures were performed, 616 without and 224 with adipose graft. The mean LEFS score increased by 7.9 and 9.8 in the two groups (out of 80), respectively, and the mean NPS score decreased from 4 to 2.6 and from 4.3 to 3 in the two groups, respectively. AE rates were 6% and 8.9% in the two groups, respectively. Although pre- and posttreatment improvements were statistically significant, the differences between the groups were not.Conclusion.BMC injections for knee OA showed encouraging outcomes and a low rate of AEs. Addition of an adipose graft to the BMC did not provide a detectible benefit over BMC alone.


Sign in / Sign up

Export Citation Format

Share Document